Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Toothbrushes may convey bacteria to the cystic fibrosis lower airways.

Passarelli Mantovani R, Sandri A, Boaretti M, Grilli A, Volpi S, Melotti P, Burlacchini G, Lleò MM, Signoretto C.

J Oral Microbiol. 2019 Aug 7;11(1):1647036. doi: 10.1080/20002297.2019.1647036. eCollection 2019.

2.

Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism.

Aalbers BL, Yaakov Y, Derichs N, Simmonds NJ, De Wachter E, Melotti P, De Boeck K, Leal T, Tümmler B, Wilschanski M, Bronsveld I.

J Cyst Fibros. 2019 Jul 19. pii: S1569-1993(19)30822-7. doi: 10.1016/j.jcf.2019.07.001. [Epub ahead of print]

PMID:
31331863
3.

Growing Trial of Gilthead Sea Bream (Sparus aurata) Juveniles Fed on Chironomid Meal as a Partial Substitution for Fish Meal.

Roncarati A, Cappuccinelli R, Meligrana MCT, Anedda R, Uzzau S, Melotti P.

Animals (Basel). 2019 Apr 3;9(4). pii: E144. doi: 10.3390/ani9040144.

4.

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD).

Solomon GM, Bronsveld I, Hayes K, Wilschanski M, Melotti P, Rowe SM, Sermet-Gaudelus I.

J Vis Exp. 2018 Sep 13;(139). doi: 10.3791/57006.

5.

When and how ruling out cystic fibrosis in adult patients with bronchiectasis.

Gramegna A, Aliberti S, Seia M, Porcaro L, Bianchi V, Castellani C, Melotti P, Sorio C, Consalvo E, Franceschi E, Amati F, Contarini M, Gaffuri M, Roncoroni L, Vigone B, Bellofiore A, Del Monaco C, Oriano M, Terranova L, Patria MF, Marchisio P, Assael BM, Blasi F.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):29. doi: 10.1186/s40248-018-0142-7. eCollection 2018. Review.

6.

Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.

Sandri A, Ortombina A, Boschi F, Cremonini E, Boaretti M, Sorio C, Melotti P, Bergamini G, Lleo M.

Virulence. 2018;9(1):1008-1018. doi: 10.1080/21505594.2018.1489198.

7.

Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects.

Bergamini G, Tridello G, Calcaterra E, Ceri S, Tagliasacchi M, Bianchi F, Monti F, Masciadri A, Laudanna E, Peserico D, Sorio E, Esposito V, Leal T, Assael BM, Sorio C, Melotti P.

J Cyst Fibros. 2018 Mar;17(2):186-189. doi: 10.1016/j.jcf.2017.12.003. Epub 2017 Dec 29.

PMID:
29292091
8.

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses.

Bergamini G, Stellari F, Sandri A, M Lleo M, Donofrio G, Ruscitti F, Boschi F, Sbarbati A, Villetti G, Melotti P, Sorio C.

J Vis Exp. 2017 Jul 7;(125). doi: 10.3791/55499.

9.

Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.

Leal T, Bergamini G, Huaux F, Panin N, Noel S, Dhooghe B, Haaf JB, Mauri P, Motta S, Di Silvestre D, Melotti P, Sorio C.

Front Immunol. 2016 Nov 15;7:499. eCollection 2016.

10.

Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts.

Cremonini E, Zonaro E, Donini M, Lampis S, Boaretti M, Dusi S, Melotti P, Lleo MM, Vallini G.

Microb Biotechnol. 2016 Nov;9(6):758-771. doi: 10.1111/1751-7915.12374. Epub 2016 Jun 20.

11.

Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis.

Straniero L, Soldà G, Costantino L, Seia M, Melotti P, Colombo C, Asselta R, Duga S.

J Hum Genet. 2016 Dec;61(12):977-984. doi: 10.1038/jhg.2016.101. Epub 2016 Aug 4.

PMID:
27488443
12.

In vivo monitoring of lung inflammation in CFTR-deficient mice.

Stellari F, Bergamini G, Ruscitti F, Sandri A, Ravanetti F, Donofrio G, Boschi F, Villetti G, Sorio C, Assael BM, Melotti P, Lleo MM.

J Transl Med. 2016 Jul 28;14(1):226. doi: 10.1186/s12967-016-0976-8.

13.

Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis.

Tridello G, Menin L, Pintani E, Bergamini G, Assael BM, Melotti P.

J Cyst Fibros. 2016 Sep;15(5):579-82. doi: 10.1016/j.jcf.2016.06.009. Epub 2016 Jul 15.

14.

Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.

Cigana C, Melotti P, Baldan R, Pedretti E, Pintani E, Iansa P, De Fino I, Favari F, Bergamini G, Tridello G, Cirillo DM, Assael BM, Bragonzi A.

BMC Microbiol. 2016 Jul 11;16(1):142. doi: 10.1186/s12866-016-0760-1.

15.

HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.

Rizzo R, Bergamini G, Bortolotti D, Leal T, D'Orazio C, Pintani E, Melchiorri L, Zavatti E, Assael BM, Sorio C, Melotti P.

Future Microbiol. 2016;11(3):363-73. doi: 10.2217/fmb.15.143. Epub 2016 Mar 2.

PMID:
26934639
16.

Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.

Sorio C, Montresor A, Bolomini-Vittori M, Caldrer S, Rossi B, Dusi S, Angiari S, Johansson JE, Vezzalini M, Leal T, Calcaterra E, Assael BM, Melotti P, Laudanna C.

Am J Respir Crit Care Med. 2016 May 15;193(10):1123-33. doi: 10.1164/rccm.201510-1922OC.

PMID:
26694899
17.

In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin.

Stellari F, Bergamini G, Sandri A, Donofrio G, Sorio C, Ruscitti F, Villetti G, Assael BM, Melotti P, Lleo MM.

J Transl Med. 2015 Aug 4;13:251. doi: 10.1186/s12967-015-0615-9.

18.

Metals in Mediterranean aquatic species.

Iamiceli A, Ubaldi A, Lucchetti D, Brambilla G, Abate V, De Felip E, De Filippis SP, Dellatte E, De Luca S, Ferri F, Fochi I, Fulgenzi A, Iacovella N, Moret I, Piazza R, Roncarati A, Melotti P, Fanelli R, Fattore E, di Domenico A, Miniero R.

Mar Pollut Bull. 2015 May 15;94(1-2):278-83. doi: 10.1016/j.marpolbul.2015.02.034. Epub 2015 Mar 18.

PMID:
25796543
19.

Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients.

Melotti P, Mafficini A, Lebecque P, Ortombina M, Leal T, Pintani E, Pepermans X, Sorio C, Assael BM.

PLoS One. 2014 Dec 12;9(12):e114274. doi: 10.1371/journal.pone.0114274. eCollection 2014.

20.

Electrophysiological evaluation of cystic fibrosis conductance transmembrane regulator (CFTR) expression in human monocytes.

Ettorre M, Verzè G, Caldrer S, Johansson J, Calcaterra E, Assael BM, Melotti P, Sorio C, Buffelli M.

Biochim Biophys Acta. 2014 Oct;1840(10):3088-95. doi: 10.1016/j.bbagen.2014.07.010. Epub 2014 Jul 18.

PMID:
25046381
21.

Persistent toxic substances in Mediterranean aquatic species.

Miniero R, Abate V, Brambilla G, Davoli E, De Felip E, De Filippis SP, Dellatte E, De Luca S, Fanelli R, Fattore E, Ferri F, Fochi I, Rita Fulgenzi A, Iacovella N, Iamiceli AL, Lucchetti D, Melotti P, Moret I, Piazza R, Roncarati A, Ubaldi A, Zambon S, di Domenico A.

Sci Total Environ. 2014 Oct 1;494-495:18-27. doi: 10.1016/j.scitotenv.2014.05.131. Epub 2014 Jul 12.

PMID:
25020099
22.

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, Quattrucci S, Rietschel E, Zeitlin PL, Barth J, Elfring GL, Welch EM, Branstrom A, Spiegel RJ, Peltz SW, Ajayi T, Rowe SM; Cystic Fibrosis Ataluren Study Group.

Lancet Respir Med. 2014 Jul;2(7):539-47. doi: 10.1016/S2213-2600(14)70100-6. Epub 2014 May 15.

23.

Detection of CFTR protein in human leukocytes by flow cytometry.

Johansson J, Vezzalini M, Verzè G, Caldrer S, Bolognin S, Buffelli M, Bellisola G, Tridello G, Assael BM, Melotti P, Sorio C.

Cytometry A. 2014 Jul;85(7):611-20. doi: 10.1002/cyto.a.22456. Epub 2014 Mar 12.

24.

Challenging the diagnosis of cystic fibrosis in a patient carrying the 186-8T/C allelic variant in the CF transmembrane conductance regulator gene.

Caldrer S, Verzè G, Johansson J, Sorio C, Angiari C, Buffelli M, Assael BM, Melotti P.

BMC Pulm Med. 2014 Mar 13;14:44. doi: 10.1186/1471-2466-14-44.

25.

Glutathione inhalation treatments in cystic fibrosis: the interference of airway γ-glutamyltransferase.

Corti A, Pompella A, Bergamini G, Melotti P.

Am J Respir Crit Care Med. 2014 Jan 15;189(2):233-4. doi: 10.1164/rccm.201305-0908LE. No abstract available.

PMID:
24428657
26.

Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.

Naehrlich L, Ballmann M, Davies J, Derichs N, Gonska T, Hjelte L, van Konigsbruggen-Rietschel S, Leal T, Melotti P, Middleton P, Tümmler B, Vermeulen F, Wilschanski M; ECFS Diagnostic Network Working Group.

J Cyst Fibros. 2014 Jan;13(1):24-8. doi: 10.1016/j.jcf.2013.08.006. Epub 2013 Sep 7.

27.

γ-Glutamyltransferase catabolism of S-nitrosoglutathione modulates IL-8 expression in cystic fibrosis bronchial epithelial cells.

Corti A, Bergamini G, Menegazzi M, Piaggi S, Bramanti E, Scataglini I, Cianchetti S, Paggiaro P, Melotti P, Pompella A.

Free Radic Biol Med. 2013 Dec;65:360-370. doi: 10.1016/j.freeradbiomed.2013.06.015. Epub 2013 Jun 29.

PMID:
23820266
28.

Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation.

Sorio C, Angiari C, Johansson J, Verzè G, Ettorre M, Buffelli M, Castellani C, Assael BM, Melotti P.

J Cyst Fibros. 2013 Dec;12(6):821-5. doi: 10.1016/j.jcf.2012.12.014. Epub 2013 Jan 27.

29.

Influence of perfusate temperature on nasal potential difference.

Bronsveld I, Vermeulen F, Sands D, Leal T, Leonard A, Melotti P, Yaakov Y, de Nooijer R, De Boeck K, Sermet I, Wilschanski M, Middleton PG; European Cystic Fibrosis Society – Diagnostic Network Working Group.

Eur Respir J. 2013 Aug;42(2):389-93. doi: 10.1183/09031936.00097712. Epub 2012 Oct 25.

30.

CFTR biomarkers: time for promotion to surrogate end-point.

De Boeck K, Kent L, Davies J, Derichs N, Amaral M, Rowe SM, Middleton P, de Jonge H, Bronsveld I, Wilschanski M, Melotti P, Danner-Boucher I, Boerner S, Fajac I, Southern K, de Nooijer RA, Bot A, de Rijke Y, de Wachter E, Leal T, Vermeulen F, Hug MJ, Rault G, Nguyen-Khoa T, Barreto C, Proesmans M, Sermet-Gaudelus I; European Cystic Fibrosis Society Clinical Trial Network Standardisation Committee.

Eur Respir J. 2013 Jan;41(1):203-16. doi: 10.1183/09031936.00057512. Epub 2012 Aug 9. Review.

31.

Development of 23 microsatellite markers for assessing genetic variability in the tub gurnard (Trigla lucerna L.).

D'Andrea M, Roncarati A, Melotti P, Scarano MT, Pilla F.

Anim Genet. 2012 Oct;43(5):650-1. doi: 10.1111/j.1365-2052.2012.02319.x. Epub 2012 Feb 9. No abstract available.

PMID:
22497668
32.

Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum.

Corti A, Franzini M, Cianchetti S, Bergamini G, Lorenzini E, Melotti P, Paolicchi A, Paggiaro P, Pompella A.

PLoS One. 2012;7(4):e34772. doi: 10.1371/journal.pone.0034772. Epub 2012 Apr 4.

33.

MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects.

Bergamini G, Di Silvestre D, Mauri P, Cigana C, Bragonzi A, De Palma A, Benazzi L, Döring G, Assael BM, Melotti P, Sorio C.

Integr Biol (Camb). 2012 Mar;4(3):270-9. doi: 10.1039/c2ib00127f. Epub 2012 Feb 1.

PMID:
22298109
34.

Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis.

Sorio C, Buffelli M, Angiari C, Ettorre M, Johansson J, Vezzalini M, Viviani L, Ricciardi M, Verzè G, Assael BM, Melotti P.

PLoS One. 2011;6(7):e22212. doi: 10.1371/journal.pone.0022212. Epub 2011 Jul 21.

35.

New clinical diagnostic procedures for cystic fibrosis in Europe.

De Boeck K, Derichs N, Fajac I, de Jonge HR, Bronsveld I, Sermet I, Vermeulen F, Sheppard DN, Cuppens H, Hug M, Melotti P, Middleton PG, Wilschanski M; ECFS Diagnostic Network Working Group; EuroCareCF WP3 Group on CF diagnosis.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S53-66. doi: 10.1016/S1569-1993(11)60009-X. Review.

36.

Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis.

Mafficini A, Ortombina M, Sermet-Gaudelius I, Lebecque P, Leal T, Iansa P, Reychler G, Dahan K, Pepermans X, Lenoir G, Leonard A, Sorio C, Assael B, Melotti P.

J Cyst Fibros. 2011 Jul;10(4):228-33. doi: 10.1016/j.jcf.2010.10.007. Epub 2011 Mar 24.

37.

An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests.

Castellani C, Perobelli S, Bianchi V, Seia M, Melotti P, Zanolla L, Assael BM, Lalatta F.

Am J Med Genet A. 2011 Apr;155A(4):778-85. doi: 10.1002/ajmg.a.33870. Epub 2011 Mar 17.

PMID:
21416590
38.

PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients.

Chiarini M, Sabelli C, Melotti P, Garlanda C, Savoldi G, Mazza C, Padoan R, Plebani A, Mantovani A, Notarangelo LD, Assael BM, Badolato R.

Genes Immun. 2010 Dec;11(8):665-70. doi: 10.1038/gene.2010.41. Epub 2010 Oct 7.

39.

Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease.

Risé P, Volpi S, Colombo C, Padoan RF, D'Orazio C, Ghezzi S, Melotti P, Bennato V, Agostoni C, Assael BM, Galli C.

J Cyst Fibros. 2010 May;9(3):228-33. doi: 10.1016/j.jcf.2010.03.002. Epub 2010 Mar 24.

40.

Editorial: The role of macrophages and their scavenger receptors in cystic fibrosis.

Sorio C, Melotti P.

J Leukoc Biol. 2009 Sep;86(3):465-8. doi: 10.1189/jlb.0309120. No abstract available.

PMID:
19720614
41.

State of the art and future trends of European and Italian aquaculture.

Melotti P, Roncarati A.

Vet Res Commun. 2009 Sep;33 Suppl 1:9-13. doi: 10.1007/s11259-009-9239-y.

PMID:
19588263
42.

CFTR mutation in an Arab patient: clinical and functional features of 875+1G-->A/875+1G-->A genotype.

Spinelli E, Seia M, Melotti P, Marchina E, Padoan R.

J Cyst Fibros. 2009 Jul;8(4):282-4. doi: 10.1016/j.jcf.2009.05.003. Epub 2009 May 28.

43.

Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells.

Bergamini G, Cigana C, Sorio C, Della Peruta M, Pompella A, Corti A, Huaux FA, Leal T, Assael BM, Melotti P.

Am J Respir Cell Mol Biol. 2009 Aug;41(2):199-206. doi: 10.1165/rcmb.2008-0013OC. Epub 2008 Dec 18.

PMID:
19097986
44.
45.

TG15 T5 allele in clinically discordant monozygotic twins with cystic fibrosis.

Picci L, Cameran M, Scarpa M, Pradal U, Melotti P, Assael BM, Castellani C.

Am J Med Genet A. 2007 Aug 15;143A(16):1936-7. No abstract available.

PMID:
17632788
46.

Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.

Cigana C, Assael BM, Melotti P.

Antimicrob Agents Chemother. 2007 Mar;51(3):975-81. Epub 2007 Jan 8.

47.

Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors.

Mafficini A, Vezzalini M, Zamai L, Galeotti L, Bergamini G, Della Peruta M, Melotti P, Sorio C.

Biomark Insights. 2007 May 31;2:218-25.

48.

Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells.

Cigana C, Nicolis E, Pasetto M, Assael BM, Melotti P.

Biochem Biophys Res Commun. 2006 Dec 1;350(4):977-82. Epub 2006 Oct 2.

PMID:
17045242
49.

Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells.

Tamanini A, Nicolis E, Bonizzato A, Bezzerri V, Melotti P, Assael BM, Cabrini G.

J Virol. 2006 Nov;80(22):11241-54. Epub 2006 Sep 6.

50.

The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis.

Nicolis E, Pasetto M, Cigana C, Pradal U, Assael BM, Melotti P.

BMC Med Genet. 2006 Feb 7;7:7.

Supplemental Content

Loading ...
Support Center